Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: National TeleOncology.
- Who it may be relevant to
- Registry conditions: Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis), Prostate Cancer Diagnosis, Breast Cancer Diagnosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.
Detailed description
Study staff will use the Veterans Health Information Systems and Technology Architecture (VistA), the VA health information technology system, to identify eligible patients at VA sites based on listed inclusion and exclusion criteria. Patient records will be observed of Veterans with a new cancer diagnosis of the lung, prostate, breast, or colon and a telehealth visit utilizing the VA National TeleOncology Service (NTO).
Interventions
- Behavioral National TeleOncology
Medical and/or subspecialty oncology care offered via facility-to-facility telehealth as an alternative to usual in-person care at the nearest VA or community oncology care setting offering similar services.
Primary outcome measures
- Number of raw telehealth visits [Time frame: Post-NTO implementation (up to 3 months)]
- Fraction of patients engaging in at least one telehealth visit [Time frame: Post-NTO implementation (up to 3 months)]
Secondary outcome measures (4)
- Change in provider level Quality Oncology Practice Initiative (QOPI) score [Time frame: Pre-implementation, post-NTO implementation (up to 3 months)]
- Time of consultation to time of first appointment [Time frame: Pre-implementation, post-NTO implementation (up to 3 months)]
- Time of consultation to time of first treatment [Time frame: Pre-implementation, post-NTO implementation (up to 3 months)]
- Average total cost for cancer diagnosis, treatment and downstream HealthCare utilization [Time frame: Post-NTO implementation (up to 3 months)]
Eligibility criteria
Patients Inclusion Criteria:
- A Veteran
- Aged 18 years or older
- Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
- Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.
VAMC Providers and Staff Inclusion Criteria:
- Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans
- Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location
Patients Exclusion Criteria:
- Veterans who have not seen any providers in the VA within the past year
- Patients previously diagnosed with lung, prostate, breast, or colon cancer
- Pregnant patients
VAMC Providers and Staff Exclusion Criteria:
1\. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 5 centers
- VA New York Harbor Healthcare System - Brooklyn — Brooklyn
- VA New York Harbor Healthcare System - St. Albans Community Living Center — Jamaica
- VA New York Harbor Health Care System - Manhattan — New York
- VA New York Harbor Healthcare System - Harlem Community Center — New York
- VA New York Harbor Healthcare System - Staten Island Community Clinic — Staten Island
Identifiers
NCT: NCT06559059 · 22-01448 · 5P50CA271358